MU
Therapeutic Areas
Devyser Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Devyser Chimerism NGS | Post-Transplantation Monitoring (HSCT) | Commercial |
| Devyser HLA Loss | Post-Transplantation Research (HLA Loss) | Commercial |
| Devyser Accept cfDNA | Post-Transplantation Monitoring (Solid Organ) | Regulatory |
| Devyser BRCA NGS | Hereditary Breast & Ovarian Cancer | Commercial |
| Devyser Thalassemia v2 | Thalassemia & Sickle Cell Disease | Commercial |
| Devyser Compact | Rapid Prenatal Aneuploidy Analysis | Commercial |